Research Directory

Success and failure in late-stage oncology

Read more

Why AstraZeneca is revisiting olaparib

Read more

The European Lead Factory: A new drug discovery platform for Europe

Read more

How BioCity Nottingham is rebuilding pharma

Read more

Empowering academic drug discovery

Read more

The EU Transparency Directive: Further debate on market access

Read more

What the Myriad case says about gene patenting

Read more

Open innovation at Progenitor Labs

Read more

Investigating the Alzheimer's disease puzzle

Read more

Advanced medical therapies attract investors

Read more